相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents
Tung M. Fong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Discovery of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity
Linus S. Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The role of the endocannabinoid system in the control of energy homeostasis
D Osei-Hyiaman et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Endocannabinoid signaling system and brain reward: Emphasis on dopamine
EL Gardner
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Rimonabant - A selective CB1 antagonist
ST Boyd et al.
ANNALS OF PHARMACOTHERAPY (2005)
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
YL Liu et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
The endocannabinoid system: a general view and latest additions
L De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB1 cannabinoid receptor antagonists
JHM Lange et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The brain's own marijuana
RA Nicoll et al.
SCIENTIFIC AMERICAN (2004)
State-level estimates of annual medical expenditures attributable to obesity
EA Finkelstein et al.
OBESITY RESEARCH (2004)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
N Jamshidi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
CS Freedland et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
SZ Hao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
